azathioprine has been researched along with Acute Liver Injury, Drug-Induced in 171 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"A prospective randomized trial in patients with Crohn disease studied whether 6-thioguanine nucleotide (6-TGN) concentration-adapted azathioprine (AZA) therapy is clinically superior to a standard dose of 2." | 9.12 | 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. ( Adler, G; Armstrong, VW; Behrens, C; Bias, P; Herfarth, H; Kruis, W; Oellerich, M; Reinshagen, M; Schütz, E; Shipkova, M; Stallmach, A; Stein, J; von Ahsen, N; von Tirpitz, C, 2007) |
"We report a case of acute severe hepatitis resulting from masitinib in a young amyotrophic lateral sclerosis patient." | 7.81 | Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. ( Camacho, J; Gamez, J; Salvado, M; Simon-Talero, M; Vargas, V; Vidal, M, 2015) |
"We report the case of a 53-year-old man with Crohn's disease who developed azathioprine-induced nodular regenerative hyperplasia of the liver." | 7.77 | [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease]. ( Corbatón, P; de la Fuente-Fernández, E; Gisbert, JP; López-Martín, C; Sánchez, MC, 2011) |
" Some histopathological features consistent with azathioprine hepatotoxicity like cholestasis, perisinusoidal fibrosis, veno-subocclusive lesions and nodular regenerative hyperplasia were also observed in this case." | 7.70 | Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? ( Aguado, JM; Colina, F; Delgado, J; Fuertes, A; Gomez, MA; Ibarrola, C; Morales, JM; Muñoz de Bustillo, E; Rodriguez, E, 1999) |
"We describe a patient with rheumatoid arthritis (RA) who developed hypersensitivity after 3 weeks of therapy with azathioprine with fever, jaundice and renal insufficiency." | 7.68 | Fever, hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity. ( Devogelaer, JP; Geubel, A; Meys, E; Nagant de Deuxchaisnes, C; Rahier, J, 1992) |
"Within one year three of 25 patients with rheumatoid arthritis treated with azathioprine 100 mg daily developed the following adverse reactions less than two weeks after starting treatment: patient one showed fever with chills, rash, and severe liver function abnormalities suggestive of cholestasis; the second patient had fever, nausea, diarrhoea, and moderately raised liver enzymes; the third patient showed very high fever and severe chills." | 7.68 | Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis. ( Boerbooms, AM; Jeurissen, ME; Kruijsen, MW; van de Putte, LB, 1990) |
"A retrospective review of the literature has been carried out to determine laboratory abnormalities occurring in patients with rheumatoid arthritis (RA) treated with azathioprine, in order to establish a profile for this agent in the treatment of this disease." | 7.66 | Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. ( Pelkey, J; Whisnant, JK, 1982) |
"Azathioprine treatment benefited 19 (66%) out of 29 patients suffering from severe psoriasis." | 7.65 | Treatment of psoriasis with azathioprine. ( Du Vivier, A; Munro, DD; Verbov, J, 1974) |
"Azathioprine is an immunosuppressive medication used in the management of many autoimmune conditions." | 6.50 | Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. ( Alam, S; Black, M; Chertoff, J; Elgendy, IY, 2014) |
"Three weeks after starting AZA for the treatment of uveitis, the patient was admitted to our clinic with cholestasis and constitutional symptoms." | 5.51 | Severe cholestasis due to azathioprine in Behcet's disease. ( Gisi, K; Ispiroglu, M; Kantarceken, B; Sayar, H, 2019) |
"Azathioprine (AZA) is an immunosuppressant frequently used for treatment of various autoimmune conditions, including MG." | 5.43 | A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. ( Hulley, D; Jack, KL; Koopman, WJ; Nicolle, MW, 2016) |
"There are substantial global differences in the preference for mercaptopurine (MP) or its prodrug azathioprine (AZA) as first-choice thiopurine to treat inflammatory bowel diseases." | 5.24 | More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. ( Broekman, MMTJ; Coenen, MJH; de Jong, DJ; Derijks, LJJ; Guchelaar, HJ; Hooymans, PM; Klungel, OH; Scheffer, H; van Marrewijk, CJ; Verbeek, ALM; Wanten, GJA; Wong, DR, 2017) |
"A prospective randomized trial in patients with Crohn disease studied whether 6-thioguanine nucleotide (6-TGN) concentration-adapted azathioprine (AZA) therapy is clinically superior to a standard dose of 2." | 5.12 | 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. ( Adler, G; Armstrong, VW; Behrens, C; Bias, P; Herfarth, H; Kruis, W; Oellerich, M; Reinshagen, M; Schütz, E; Shipkova, M; Stallmach, A; Stein, J; von Ahsen, N; von Tirpitz, C, 2007) |
" The variety of acute hepatitis include hepatitis A, hepatitis B, cytomegalovirus hepatitis, herpes simplex hepatitis and azathioprine hepatitis." | 4.75 | Liver disease in renal transplant recipients. ( Anuras, S; Sopko, J, 1978) |
" Acute cholestasis is one of the most common forms of hepatotoxicity induced by azathioprine." | 4.12 | Severe azathioprine-induced liver injury 22 months after initiation of treatment. ( Battezzati, PM; Cataletti, G; Pastorelli, L; Santagata, F, 2022) |
"We report a case of acute severe hepatitis resulting from masitinib in a young amyotrophic lateral sclerosis patient." | 3.81 | Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. ( Camacho, J; Gamez, J; Salvado, M; Simon-Talero, M; Vargas, V; Vidal, M, 2015) |
"Thiopurines (azathioprine, 6-mercaptopurine) are a mainstay of treatment in Crohn disease (CD)." | 3.80 | Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease. ( Amre, D; Deslandres, C; Kopylov, U; Seidman, EG; Theoret, Y, 2014) |
"We report the case of a 53-year-old man with Crohn's disease who developed azathioprine-induced nodular regenerative hyperplasia of the liver." | 3.77 | [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease]. ( Corbatón, P; de la Fuente-Fernández, E; Gisbert, JP; López-Martín, C; Sánchez, MC, 2011) |
" Some histopathological features consistent with azathioprine hepatotoxicity like cholestasis, perisinusoidal fibrosis, veno-subocclusive lesions and nodular regenerative hyperplasia were also observed in this case." | 3.70 | Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? ( Aguado, JM; Colina, F; Delgado, J; Fuertes, A; Gomez, MA; Ibarrola, C; Morales, JM; Muñoz de Bustillo, E; Rodriguez, E, 1999) |
"Azathioprine and rheumatoid arthritis are known to be associated with an increased risk of the development of non-Hodgkin's lymphoma; however, the manifestation of fulminant hepatic failure is extremely uncommon in patients with non-Hodgkin's lymphoma." | 3.69 | Azathioprine-induced lymphoma manifesting as fulminant hepatic failure. ( Aguilar, HI; Burgart, LJ; Geller, A; Rakela, J, 1997) |
"Within one year three of 25 patients with rheumatoid arthritis treated with azathioprine 100 mg daily developed the following adverse reactions less than two weeks after starting treatment: patient one showed fever with chills, rash, and severe liver function abnormalities suggestive of cholestasis; the second patient had fever, nausea, diarrhoea, and moderately raised liver enzymes; the third patient showed very high fever and severe chills." | 3.68 | Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis. ( Boerbooms, AM; Jeurissen, ME; Kruijsen, MW; van de Putte, LB, 1990) |
"We describe a patient with rheumatoid arthritis (RA) who developed hypersensitivity after 3 weeks of therapy with azathioprine with fever, jaundice and renal insufficiency." | 3.68 | Fever, hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity. ( Devogelaer, JP; Geubel, A; Meys, E; Nagant de Deuxchaisnes, C; Rahier, J, 1992) |
"Three cases of azathioprine-induced complex of liver diseases are described, and their light microscopy and ultrastructural findings are detailed." | 3.67 | Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. ( Ackrill, P; Ali, HH; Haboubi, NY; Whitwell, HL, 1988) |
"A retrospective review of the literature has been carried out to determine laboratory abnormalities occurring in patients with rheumatoid arthritis (RA) treated with azathioprine, in order to establish a profile for this agent in the treatment of this disease." | 3.66 | Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. ( Pelkey, J; Whisnant, JK, 1982) |
"Azathioprine treatment benefited 19 (66%) out of 29 patients suffering from severe psoriasis." | 3.65 | Treatment of psoriasis with azathioprine. ( Du Vivier, A; Munro, DD; Verbov, J, 1974) |
"Hepatotoxicity, gastrointestinal complaints and general malaise are common limiting adverse reactions of azathioprine and mercaptopurine in IBD patients, often related to high steady-state 6-methylmercaptopurine ribonucleotide (6-MMPR) metabolite concentrations." | 2.84 | Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease. ( Coenen, MJ; de Jong, DJ; Derijks, LJ; Engels, LG; Franke, B; Guchelaar, HJ; Hooymans, PM; Klungel, OH; Scheffer, H; van Marrewijk, CJ; Verbeek, AL; Vermeulen, SH; Wong, DR, 2017) |
" However, adverse events leading to discontinuation may occur in 10-20% of patients." | 2.71 | 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. ( de Jong, DJ; Derijks, LJ; Engels, LG; Gilissen, LP; Hooymans, PM; Jansen, JB; Mulder, CJ, 2003) |
" Fortunately, the absolute incidence of serious toxicity remains low, and an improved understanding of how best to minimize risk and the recognition of groups of patients at higher risk of toxicity from thiopurines means that they remain a relatively safe therapy in the majority of patients." | 2.52 | Toxicity and response to thiopurines in patients with inflammatory bowel disease. ( Goldberg, R; Irving, PM, 2015) |
" However, the dosing and the duration of immunosuppressive therapy have not been systematically studied in the setting of treating ipilimumab-induced irAEs." | 2.52 | Ipilimumab-induced toxicities and the gastroenterologist. ( Bye, W; Cheng, R; Cooper, A; Kench, J; McNeil, C; Shackel, N; Watson, G, 2015) |
"Azathioprine is an immunosuppressive medication used in the management of many autoimmune conditions." | 2.50 | Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. ( Alam, S; Black, M; Chertoff, J; Elgendy, IY, 2014) |
"The addition of low dose allopurinol to dose-reduced thiopurine analogue seems safe but careful monitoring for adverse effects and profiling of thiopurine metabolites is essential." | 2.44 | Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol. ( Gearry, RB; Leong, RW; Sparrow, MP, 2008) |
"Azathioprine was not associated with thrombocytopenia, anaemia or neutropenia in any dogs." | 1.72 | Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs. ( Eberhardy, AC; Heinrich, NA; McFadden, RA; Reiter, LV, 2022) |
"Approximately 25% of patients with inflammatory bowel disease (IBD) discontinue azathioprine (AZA) or mercaptopurine (MP) therapy within 3 months of treatment initiation because of adverse drug reactions." | 1.72 | Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients. ( Bus, P; Creemers, RH; de Boer, NKH; Deben, DS; Pierik, MJ; Simsek, M; van Bodegraven, AA; van Moorsel, SAW; Winkens, B; Wong, DR, 2022) |
"Three weeks after starting AZA for the treatment of uveitis, the patient was admitted to our clinic with cholestasis and constitutional symptoms." | 1.51 | Severe cholestasis due to azathioprine in Behcet's disease. ( Gisi, K; Ispiroglu, M; Kantarceken, B; Sayar, H, 2019) |
"A 15-year-old girl was diagnosed with influenza and prescribed 40 mg laninamivir." | 1.51 | Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate. ( Arinaga-Hino, T; Hirai, S; Ide, T; Kawaguchi, T; Nagamatsu, H; Shimizu, M; Takata, A; Tanikawa, K; Tateishi, H; Tokushige, T; Torimura, T, 2019) |
" Indications for switch, dosing and subsequent clinical outcomes (including thiopurine persistence) were recorded." | 1.48 | Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. ( Beswick, L; Friedman, AB; Haridy, J; Moltzen, A; Raghunath, A; Sparrow, M; van Langenberg, D; Vasudevan, A, 2018) |
" Moreover, acute liver failure after multiple dosing of azathioprine was investigated in a patient case study by use of own clinical data." | 1.46 | Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients. ( Blank, LM; Castell, JV; Conde, I; Cordes, H; Kuepfer, L; Thiel, C, 2017) |
"Azathioprine (AZA) is an immunosuppressant frequently used for treatment of various autoimmune conditions, including MG." | 1.43 | A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. ( Hulley, D; Jack, KL; Koopman, WJ; Nicolle, MW, 2016) |
"Overall, 113/164 (69%) patients with Crohn's disease and 83/136 (61%) patients with ulcerative/unclassified colitis had a clinical response by the end of follow-up (median 19 months), while 85 (52%) patients with Crohn's disease and 74 (54%) patients with ulcerative/unclassified colitis were in clinical remission." | 1.43 | Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study. ( Abdulrehman, A; Ansari, A; Bull, C; Duley, J; Kerr, P; Pavlidis, P; Stamoulos, P, 2016) |
" This study aims to detect TPMT polymorphisms and TPMT enzyme activity in Chinese SLE patients and to describe the association between TPMT genotypes and adverse effects of AZA." | 1.40 | Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus. ( Chen, D; Lian, F; Liang, L; Qiu, Q; Wang, Y; Xu, H; Yang, X; Ye, Y; Yuan, S; Zhan, Z, 2014) |
"A retrospective cohort of 176 Crohn's Disease (CD) patients treated with thiopurines (131 with 6MP and 45 with azathioprine) was genotyped for common polymorphisms in GSTM1, GSTT1 and TPMT." | 1.39 | Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease. ( Chowers, Y; Efrati, E; Elkin, H; Karban, A; Koifman, E; Krivoy, N; Mazor, Y, 2013) |
" The primary outcome was the occurrence of 6-thioguanine induced hepatotoxicity, scaled according to the Common Terminology Criteria for Adverse Events." | 1.38 | Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment. ( de Boer, NK; Mulder, CJ; Seinen, ML; van Asseldonk, DP; van Bodegraven, AA, 2012) |
" 13 adverse events occurred, including 6 specific to co-therapy (3 rash, 2 abnormal liver function tests, 1 dosing error)." | 1.38 | Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. ( Anderson, SH; Blaker, P; Irving, PM; Marinaki, AM; Sanderson, JD; Smith, MA, 2012) |
"Patients with ornidazole-induced toxic hepatitis with autoimmune hepatitis were included to constitute the study group of this report." | 1.37 | Ornidazole-induced autoimmune hepatitis. ( Akarca, US; Ersöz, G; Günşar, F; Karasu, Z; Tekın, F; Vardar, R; Yilmaz, F, 2011) |
" We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
"Immunosuppressants are among the pharmacological agents with the greatest potential to cause adverse reactions, although induction of hepatotoxicity is paradoxical from the pathogenic point of view, since the response of the innate and acquired immune system is a key element in the chain of events leading to chemical liver damage." | 1.36 | [Hepatotoxicity induced by new immunosuppressants]. ( Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E, 2010) |
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems." | 1.36 | Developing structure-activity relationships for the prediction of hepatotoxicity. ( Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010) |
"Following repeated liver biopsy, autoimmune hepatitis was assumed and prednisolone and azathioprine were initiated." | 1.35 | [Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report]. ( Hartmann, U; Reuss-Borst, M; Schmitt, S, 2008) |
"Two patients developed acute pancreatitis." | 1.34 | Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. ( Bohane, TD; Day, AS; Lee, D; Naidoo, D; Ooi, CY, 2007) |
"61); among the 34 responders, the median dosage of the drug required to obtain remission was lower for mutated than for wild type patients (1." | 1.33 | TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. ( Barabino, A; Bartoli, F; Decorti, G; Fezzi, M; Fontana, M; Giraldi, T; Lionetti, P; Malusà, N; Martelossi, S; Stocco, G; Ventura, A, 2005) |
"Azathioprine (AZA) is an important drug used in the therapy of autoimmune system disorders." | 1.32 | A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine. ( Ahmad, M; Al-Shabanah, OA; Gado, A; Raza, M, 2003) |
"Twenty-two per cent of patients discontinued azathioprine prematurely probably as a result of related adverse events." | 1.32 | Side effects of azathioprine in patients with Crohn's disease. ( de Jong, DJ; Goullet, M; Naber, TH, 2004) |
"Azathioprine was discontinued." | 1.27 | Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature. ( Creutzfeldt, W; Eisenhauer, T; Hartmann, H; Helmchen, U; Rumpf, KW; Scheler, F, 1984) |
"Azathioprine was discontinued." | 1.27 | Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature. ( Adler, M; Cremer, M; De Pauw, L; Delhaye, M; Deprez, C; Gelin, M; Hardy, N; Toussaint, C; Vereerstraeten, P, 1987) |
"Azathioprine was later withdrawn in 29 (66%), in 6 because of side effects and in 20 because of clinical and biochemical improvement." | 1.27 | Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade. ( Elgjo, K; Opedal, I; Ritland, S, 1985) |
"Esophageal varices were demonstrated." | 1.27 | Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation. ( Assmann, KM; Deckers, PF; Driessen, WM; Gerlag, PG; Lobatto, S; Schröder, E; Van Haelst, UJ; Van Hooff, JP, 1985) |
" Neither histopathological changes were observed, nor could any deaths be directly attributed to toxic effects of the drug on hepatocytes." | 1.26 | Azathioprine hepatotoxicity, direct complication or secondary effect in rat liver transplantation. ( Hess, F; Jerusalem, C; Polak, M, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 69 (40.35) | 18.7374 |
1990's | 15 (8.77) | 18.2507 |
2000's | 26 (15.20) | 29.6817 |
2010's | 55 (32.16) | 24.3611 |
2020's | 6 (3.51) | 2.80 |
Authors | Studies |
---|---|
Fourches, D | 1 |
Barnes, JC | 1 |
Day, NC | 1 |
Bradley, P | 1 |
Reed, JZ | 1 |
Tropsha, A | 1 |
Greene, N | 1 |
Fisk, L | 1 |
Naven, RT | 1 |
Note, RR | 1 |
Patel, ML | 1 |
Pelletier, DJ | 1 |
Morgan, RE | 2 |
Trauner, M | 1 |
van Staden, CJ | 2 |
Lee, PH | 1 |
Ramachandran, B | 1 |
Eschenberg, M | 1 |
Afshari, CA | 2 |
Qualls, CW | 1 |
Lightfoot-Dunn, R | 1 |
Hamadeh, HK | 2 |
Ekins, S | 1 |
Williams, AJ | 1 |
Xu, JJ | 1 |
Chen, M | 2 |
Vijay, V | 1 |
Shi, Q | 2 |
Liu, Z | 2 |
Fang, H | 2 |
Tong, W | 3 |
Dawson, S | 1 |
Stahl, S | 2 |
Paul, N | 1 |
Barber, J | 1 |
Kenna, JG | 2 |
Ding, D | 1 |
Kelly, R | 1 |
Sakatis, MZ | 1 |
Reese, MJ | 1 |
Harrell, AW | 1 |
Taylor, MA | 1 |
Baines, IA | 1 |
Chen, L | 1 |
Bloomer, JC | 1 |
Yang, EY | 1 |
Ellens, HM | 1 |
Ambroso, JL | 1 |
Lovatt, CA | 1 |
Ayrton, AD | 1 |
Clarke, SE | 1 |
Warner, DJ | 1 |
Chen, H | 1 |
Cantin, LD | 1 |
Walker, CL | 1 |
Noeske, T | 1 |
Chen, Y | 1 |
Kalyanaraman, N | 1 |
Kalanzi, J | 1 |
Dunn, RT | 1 |
Suzuki, A | 1 |
Thakkar, S | 1 |
Yu, K | 1 |
Hu, C | 1 |
Abdul-Hamid, M | 1 |
Abdel-Reheim, ES | 1 |
Hegazy, W | 1 |
Allam, A | 1 |
Othman, SI | 1 |
Alwaele, MA | 1 |
Abdel-Kawi, SH | 1 |
Eberhardy, AC | 1 |
Heinrich, NA | 1 |
McFadden, RA | 1 |
Reiter, LV | 1 |
van Moorsel, SAW | 1 |
Deben, DS | 1 |
Creemers, RH | 1 |
Winkens, B | 1 |
Bus, P | 1 |
Pierik, MJ | 1 |
Simsek, M | 1 |
de Boer, NKH | 1 |
van Bodegraven, AA | 2 |
Wong, DR | 3 |
Cataletti, G | 1 |
Santagata, F | 1 |
Pastorelli, L | 1 |
Battezzati, PM | 1 |
Phillips, J | 1 |
Preskey, R | 1 |
Penfold, C | 1 |
Gordon, F | 1 |
Tyrrell-Price, J | 1 |
Nakashima, K | 1 |
Demura, Y | 1 |
Oi, M | 1 |
Tabata, M | 1 |
Tada, T | 1 |
Shiozaki, K | 1 |
Akai, M | 1 |
Ishizuka, T | 1 |
Siramolpiwat, S | 1 |
Sakonlaya, D | 1 |
Iwamoto, K | 1 |
Ishitsuka, Y | 1 |
Tanaka, R | 1 |
Sekine, I | 1 |
Fujimoto, M | 1 |
Broekman, MMTJ | 1 |
Coenen, MJH | 1 |
van Marrewijk, CJ | 2 |
Wanten, GJA | 1 |
Verbeek, ALM | 1 |
Klungel, OH | 2 |
Hooymans, PM | 3 |
Guchelaar, HJ | 2 |
Scheffer, H | 2 |
Derijks, LJJ | 1 |
de Jong, DJ | 4 |
Koller, T | 1 |
Galambosova, M | 1 |
Filakovska, S | 1 |
Kubincova, M | 1 |
Hlavaty, T | 1 |
Toth, J | 1 |
Krajcovicova, A | 1 |
Payer, J | 1 |
Vasudevan, A | 1 |
Beswick, L | 1 |
Friedman, AB | 1 |
Moltzen, A | 1 |
Haridy, J | 1 |
Raghunath, A | 1 |
Sparrow, M | 1 |
van Langenberg, D | 1 |
Wang, CH | 1 |
Chi, MH | 1 |
Lin, JY | 1 |
Chung, WH | 1 |
Chen, CB | 1 |
Gisi, K | 1 |
Ispiroglu, M | 1 |
Kantarceken, B | 1 |
Sayar, H | 1 |
Kawaguchi, T | 1 |
Arinaga-Hino, T | 1 |
Shimizu, M | 1 |
Tanikawa, K | 1 |
Tokushige, T | 1 |
Hirai, S | 1 |
Nagamatsu, H | 1 |
Tateishi, H | 1 |
Takata, A | 1 |
Ide, T | 1 |
Torimura, T | 1 |
Ruiz-Clavijo, D | 1 |
Arín, A | 1 |
Vila, JJ | 1 |
Albéniz, E | 1 |
Picazo, R | 1 |
Casi, M | 1 |
Matsuo, K | 1 |
Sasaki, E | 1 |
Higuchi, S | 1 |
Takai, S | 1 |
Tsuneyama, K | 1 |
Fukami, T | 1 |
Nakajima, M | 1 |
Yokoi, T | 1 |
Chen, D | 2 |
Lian, F | 1 |
Yuan, S | 1 |
Wang, Y | 1 |
Zhan, Z | 1 |
Ye, Y | 1 |
Qiu, Q | 1 |
Xu, H | 1 |
Liang, L | 1 |
Yang, X | 1 |
Ahmed, WM | 1 |
Khalaf, AA | 1 |
Moselhy, WA | 1 |
Safwat, GM | 1 |
Kopylov, U | 1 |
Amre, D | 1 |
Theoret, Y | 1 |
Deslandres, C | 1 |
Seidman, EG | 2 |
Vo, HD | 1 |
Xu, J | 1 |
Rabinowitz, SS | 1 |
Fisher, SE | 1 |
Schwarz, SM | 1 |
Trabelsi, AB | 1 |
Hamami, E | 1 |
Souguir, A | 1 |
Ksiaa, M | 1 |
Ajmi, S | 1 |
Jmaa, A | 1 |
Chertoff, J | 1 |
Alam, S | 1 |
Black, M | 1 |
Elgendy, IY | 1 |
Cheng, R | 1 |
Cooper, A | 1 |
Kench, J | 1 |
Watson, G | 1 |
Bye, W | 1 |
McNeil, C | 1 |
Shackel, N | 1 |
Goldberg, R | 1 |
Irving, PM | 2 |
Schröder, T | 1 |
Schmidt, KJ | 1 |
Olsen, V | 1 |
Möller, S | 1 |
Mackenroth, T | 1 |
Sina, C | 1 |
Lehnert, H | 1 |
Fellermann, K | 1 |
Büning, J | 1 |
Lin, KM | 1 |
Cheng, TT | 1 |
Lin, JC | 1 |
Chen, CJ | 1 |
Salvado, M | 1 |
Vargas, V | 1 |
Vidal, M | 1 |
Simon-Talero, M | 1 |
Camacho, J | 1 |
Gamez, J | 1 |
Thiel, C | 1 |
Cordes, H | 1 |
Conde, I | 1 |
Castell, JV | 1 |
Blank, LM | 1 |
Kuepfer, L | 1 |
Pavlidis, P | 1 |
Stamoulos, P | 1 |
Abdulrehman, A | 1 |
Kerr, P | 1 |
Bull, C | 1 |
Duley, J | 1 |
Ansari, A | 1 |
Jack, KL | 1 |
Koopman, WJ | 1 |
Hulley, D | 1 |
Nicolle, MW | 1 |
Björnsson, ES | 1 |
Gu, J | 1 |
Kleiner, DE | 1 |
Chalasani, N | 1 |
Hayashi, PH | 1 |
Hoofnagle, JH | 1 |
Coenen, MJ | 1 |
Derijks, LJ | 4 |
Vermeulen, SH | 1 |
Franke, B | 1 |
Engels, LG | 2 |
Verbeek, AL | 1 |
Leong, RW | 1 |
Gearry, RB | 4 |
Sparrow, MP | 1 |
Gardiner, SJ | 1 |
Burt, MJ | 1 |
Ding, SL | 1 |
Barclay, ML | 2 |
Kiefer, K | 1 |
El-Matary, W | 1 |
Xin, HW | 1 |
Xiong, H | 1 |
Wu, XC | 1 |
Li, Q | 1 |
Xiong, L | 1 |
Yu, AR | 1 |
Martínez-Odriozola, P | 1 |
Gutiérrez-Macías, A | 1 |
Ibarmia-Lahuerta, J | 1 |
Muñóz-Sánchez, J | 1 |
Takatsu, N | 1 |
Matsui, T | 1 |
Murakami, Y | 1 |
Ishihara, H | 1 |
Hisabe, T | 1 |
Nagahama, T | 1 |
Maki, S | 1 |
Beppu, T | 1 |
Takaki, Y | 1 |
Hirai, F | 1 |
Yao, K | 1 |
Bermejo, F | 1 |
López-Sanromán, A | 1 |
Algaba, A | 1 |
Van-Domselaar, M | 1 |
Gisbert, JP | 4 |
García-Garzón, S | 1 |
Garrido, E | 1 |
Piqueras, B | 1 |
De La Poza, G | 1 |
Guerra, I | 1 |
Toscano, E | 1 |
Cotta, J | 1 |
Robles, M | 1 |
Lucena, MA | 1 |
Andrade, RJ | 1 |
Andrejic, J | 1 |
Rojas-Balcazar, J | 1 |
Dennis, M | 1 |
Berkelhammer, C | 1 |
Okan, G | 1 |
Vural, P | 1 |
Peker, O | 1 |
Colakoglu, E | 1 |
Saruc, M | 1 |
Bryant, DL | 1 |
Miles, CJ | 1 |
Błogowski, W | 1 |
Marlicz, W | 1 |
Smereczyński, A | 1 |
Lawniczak, M | 1 |
Lewosiuk, A | 1 |
Starzyńska, T | 1 |
Hunt, CM | 1 |
Roberts, RL | 1 |
López-Martín, C | 1 |
de la Fuente-Fernández, E | 1 |
Corbatón, P | 1 |
Sánchez, MC | 1 |
Srirajaskanthan, R | 1 |
Valliani, D | 1 |
Meggitt, SJ | 1 |
Anstey, AV | 1 |
Mohd Mustapa, MF | 1 |
Reynolds, NJ | 1 |
Wakelin, S | 1 |
Ersöz, G | 1 |
Vardar, R | 1 |
Akarca, US | 1 |
Tekın, F | 1 |
Yilmaz, F | 1 |
Günşar, F | 1 |
Karasu, Z | 1 |
van Asseldonk, DP | 1 |
Seinen, ML | 1 |
de Boer, NK | 2 |
Mulder, CJ | 3 |
Smith, MA | 1 |
Blaker, P | 1 |
Marinaki, AM | 1 |
Anderson, SH | 1 |
Sanderson, JD | 1 |
Choudhary, NS | 1 |
Gupta, S | 1 |
Chawla, YK | 1 |
Duseja, A | 1 |
Dhiman, RK | 1 |
Das, A | 1 |
Appell, ML | 1 |
Wagner, A | 1 |
Hindorf, U | 1 |
Gilissen, LP | 2 |
Jansen, JB | 1 |
Raza, M | 1 |
Ahmad, M | 1 |
Gado, A | 1 |
Al-Shabanah, OA | 1 |
Goullet, M | 1 |
Naber, TH | 1 |
Eisenbach, C | 1 |
Goeggelmann, C | 1 |
Flechtenmacher, C | 1 |
Stremmel, W | 1 |
Encke, J | 1 |
Amin, A | 1 |
Hamza, AA | 1 |
Stocco, G | 1 |
Martelossi, S | 1 |
Barabino, A | 1 |
Fontana, M | 1 |
Lionetti, P | 1 |
Decorti, G | 1 |
Malusà, N | 1 |
Bartoli, F | 1 |
Fezzi, M | 1 |
Giraldi, T | 1 |
Ventura, A | 1 |
Bastida, G | 1 |
Nos, P | 1 |
Aguas, M | 1 |
Beltrán, B | 1 |
Rubín, A | 1 |
Dasí, F | 1 |
Ponce, J | 1 |
Zelinkova, Z | 1 |
Stokkers, PC | 1 |
Vogels, EW | 1 |
van Kampen, AH | 1 |
Curvers, WL | 1 |
Cohn, D | 1 |
van Deventer, SJ | 1 |
Hommes, DW | 1 |
Wu, YT | 1 |
Shen, C | 1 |
Yin, J | 1 |
Yu, JP | 1 |
Meng, Q | 1 |
Soto-Fernández, S | 1 |
González-Carro, P | 1 |
De Pedro-Esteban, A | 1 |
Legaz-Huidobro, ML | 1 |
Pérez-Roldán, F | 1 |
Roncero García-Escribano, O | 1 |
Valbuena-González, M | 1 |
Ruiz-Carrillo, F | 1 |
González-Lama, Y | 2 |
Maté, J | 2 |
Ooi, CY | 1 |
Bohane, TD | 1 |
Lee, D | 1 |
Naidoo, D | 1 |
Day, AS | 1 |
Luna, M | 1 |
Pousa, ID | 1 |
Velasco, M | 1 |
Moreno-Otero, R | 1 |
Shaye, OA | 1 |
Yadegari, M | 1 |
Abreu, MT | 2 |
Poordad, F | 1 |
Simon, K | 1 |
Martin, P | 1 |
Papadakis, KA | 1 |
Ippoliti, A | 1 |
Vasiliauskas, E | 1 |
Tran, TT | 1 |
Hartmann, U | 1 |
Schmitt, S | 1 |
Reuss-Borst, M | 1 |
Teruel, JL | 1 |
Marcén, R | 1 |
Celma, ML | 1 |
Bueno, R | 1 |
Jiménez del Cerro, L | 1 |
Matesanz, R | 1 |
Quereda, C | 1 |
Ortuño, J | 1 |
Cohen, DJ | 1 |
Loertscher, R | 1 |
Rubin, MF | 1 |
Tilney, NL | 2 |
Carpenter, CB | 2 |
Strom, TB | 2 |
Milford, EL | 1 |
Araujo, JL | 1 |
Kirkman, RL | 1 |
Eisenhauer, T | 1 |
Hartmann, H | 1 |
Rumpf, KW | 1 |
Helmchen, U | 1 |
Scheler, F | 1 |
Creutzfeldt, W | 1 |
Harvey, C | 1 |
Dixon, JS | 1 |
Bird, HA | 1 |
Aprosina, ZG | 1 |
Obata, T | 1 |
Watanabe, A | 3 |
Hayashi, S | 1 |
Higashi, T | 1 |
Endo, H | 2 |
Nagashima, H | 3 |
Horimi, T | 1 |
Huchimoto, S | 1 |
Sakagami, K | 1 |
Orita, K | 1 |
Kusaba, R | 1 |
Otubo, O | 1 |
Sugimoto, H | 1 |
Takahashi, I | 1 |
Yamada, Y | 1 |
Yamauchi, J | 1 |
Akiyama, N | 1 |
Inou, T | 1 |
Klintmalm, GB | 1 |
Iwatsuki, S | 1 |
Starzl, TE | 2 |
Whisnant, JK | 1 |
Pelkey, J | 1 |
Jazzar, A | 1 |
Fagiuoli, S | 1 |
Caraceni, P | 1 |
Deal, S | 1 |
Wright, HI | 1 |
Sisson, S | 1 |
Gavaler, J | 1 |
Van Thiel, DH | 1 |
Zuhdi, N | 1 |
Cooper, DK | 1 |
Gross, R | 1 |
Pol, S | 1 |
Cavalcanti, R | 1 |
Carnot, F | 1 |
Legendre, C | 1 |
Driss, F | 1 |
Chaix, ML | 1 |
Thervet, E | 1 |
Chkoff, N | 1 |
Brechot, C | 1 |
Berthelot, P | 1 |
Kreis, H | 2 |
de la Serna Higuera, C | 1 |
Moreira Vicente, VE | 1 |
Sanz de Villalobos, E | 1 |
Dubost, JJ | 1 |
Abergel, A | 1 |
Soubrier, M | 1 |
Bommelaer, G | 1 |
Sauvezie, B | 1 |
Aguilar, HI | 1 |
Burgart, LJ | 1 |
Geller, A | 1 |
Rakela, J | 1 |
Farrell, GC | 1 |
Pittau, S | 1 |
Morelli, S | 1 |
Venturini, E | 1 |
Boldorini, R | 1 |
Sartori, M | 1 |
Sun, C | 1 |
Qu, Z | 1 |
Hao, J | 1 |
Wang, J | 1 |
Roland, S | 1 |
Delwaide, J | 1 |
Cornet, G | 1 |
Mahieu, P | 1 |
Jacquet, N | 1 |
Belaiche, J | 1 |
Delgado, J | 1 |
Muñoz de Bustillo, E | 1 |
Ibarrola, C | 1 |
Colina, F | 1 |
Morales, JM | 1 |
Rodriguez, E | 1 |
Aguado, JM | 1 |
Fuertes, A | 1 |
Gomez, MA | 1 |
Castiglione, F | 1 |
Del Vecchio Blanco, G | 1 |
Rispo, A | 1 |
Cozzolino, A | 1 |
Di Girolamo, E | 1 |
Cappuccio, D | 1 |
Mazzacca, G | 1 |
del Valle García Sánchez, M | 1 |
Poyato González, A | 1 |
Gómez Camacho, F | 1 |
Luisa Vignote Alguacil, M | 1 |
Lytton, SD | 1 |
Berg, U | 1 |
Nemeth, A | 1 |
Ingelman-Sundberg, M | 1 |
Dubinsky, MC | 1 |
Yang, H | 1 |
Hassard, PV | 1 |
Kam, LY | 1 |
Targan, SR | 1 |
Vasiliauskas, EA | 1 |
Köttgen, E | 1 |
Gerok, W | 1 |
Hobara, N | 2 |
Rassner, G | 1 |
Schein, PS | 1 |
Winokur, SH | 1 |
Ware, AJ | 1 |
Luby, JP | 1 |
Eigenbrodt, EH | 1 |
Long, DL | 1 |
Hull, AR | 1 |
Berne, TV | 1 |
Chatterjee, SN | 1 |
Craig, JR | 1 |
Payne, JE | 1 |
Sopko, J | 1 |
Anuras, S | 1 |
Mozes, MF | 1 |
Ascher, NL | 1 |
Balfour, HH | 1 |
Simmons, RL | 1 |
Najarian, JS | 1 |
Tobe, K | 1 |
Knoblauch, M | 2 |
Andreu, J | 1 |
Caralps, A | 1 |
Brulles, A | 1 |
Lloveras, J | 1 |
Masramon, J | 1 |
Gil-Vernet, JM | 1 |
Hess, F | 1 |
Jerusalem, C | 1 |
Polak, M | 1 |
Barbanel, C | 1 |
Crosnier, J | 1 |
Sherlock, S | 2 |
Marubbio, AT | 1 |
Danielson, B | 1 |
Lämmli, J | 1 |
Funk, C | 1 |
Pickering, RW | 1 |
Lynn James, GW | 1 |
Parker, FL | 1 |
Meys, E | 1 |
Devogelaer, JP | 1 |
Geubel, A | 1 |
Rahier, J | 1 |
Nagant de Deuxchaisnes, C | 1 |
García, R | 1 |
Marín, C | 1 |
Herrera, J | 1 |
Henríquez La Roche, C | 1 |
Rubio, L | 1 |
Rodríguez-Iturbe, B | 1 |
Urowitz, MB | 1 |
Lee, P | 1 |
Jeurissen, ME | 1 |
Boerbooms, AM | 1 |
van de Putte, LB | 1 |
Kruijsen, MW | 1 |
Small, P | 1 |
Lichter, M | 1 |
Clements, PJ | 1 |
Davis, J | 1 |
Sandrini, S | 1 |
Scolari, F | 1 |
Savoldi, S | 1 |
Brunori, G | 1 |
Callea, F | 1 |
Tardanico, R | 1 |
Facchetti, F | 1 |
Delaini, C | 1 |
Cristinelli, L | 1 |
Maiorca, R | 1 |
Adler, M | 1 |
Delhaye, M | 1 |
Deprez, C | 1 |
Hardy, N | 1 |
Gelin, M | 1 |
De Pauw, L | 1 |
Vereerstraeten, P | 1 |
Cremer, M | 1 |
Toussaint, C | 1 |
Haboubi, NY | 1 |
Ali, HH | 1 |
Whitwell, HL | 1 |
Ackrill, P | 1 |
García Buey, L | 1 |
Moreno Otero, R | 1 |
García Sánchez, A | 1 |
González Estecha, A | 1 |
Pajares, JM | 1 |
Gerlag, PG | 2 |
van Hooff, JP | 2 |
Wakabayashi, T | 1 |
Mori, S | 1 |
Pastolero, J | 1 |
Sugimura, H | 1 |
Katzka, DA | 1 |
Saul, SH | 1 |
Jorkasky, D | 1 |
Sigal, H | 1 |
Reynolds, JC | 1 |
Soloway, RD | 1 |
Cooper, C | 1 |
Cotton, DW | 1 |
Minihane, N | 1 |
Cawley, MI | 1 |
Opedal, I | 1 |
Ritland, S | 1 |
Elgjo, K | 1 |
Lobatto, S | 1 |
Driessen, WM | 1 |
Deckers, PF | 1 |
Schröder, E | 1 |
Assmann, KM | 1 |
Van Haelst, UJ | 1 |
Greif, J | 1 |
Erdmann, E | 1 |
Barrowman, JA | 1 |
Kutty, PK | 1 |
Ra, MU | 1 |
Huang, SN | 1 |
Aronsen, KF | 2 |
Husberg, B | 2 |
Hägerstrand, I | 1 |
Nordén, JG | 1 |
Pihl, B | 2 |
Baumann, W | 1 |
Götzel, L | 1 |
Mertens, HG | 1 |
Balzereit, F | 1 |
Leipert, M | 1 |
Malekzadeh, MH | 1 |
Grushkin, CM | 1 |
Wright, HT | 1 |
Fine, RN | 1 |
Fung, WP | 1 |
Zarday, Z | 1 |
Veith, FJ | 1 |
Gliedman, ML | 1 |
Soberman, R | 1 |
McNicol, GP | 1 |
Davies, JA | 1 |
Klatskin, G | 1 |
Kantor, FS | 1 |
Putnam, CW | 1 |
Ross, RC | 1 |
Kovacs, K | 1 |
Horvath, E | 1 |
Ireland, P | 1 |
Rashid, A | 1 |
von Lichtenberg, F | 1 |
Cavallo, T | 1 |
Merrill, JP | 1 |
Gould, DB | 1 |
Falcao, H | 1 |
Galdabini, J | 1 |
Stummvoll, HK | 1 |
Egert, H | 1 |
Böhmig, HJ | 1 |
Pinggera, WF | 1 |
Lesesne, HR | 1 |
Fallon, HJ | 1 |
Herzberg, JJ | 1 |
Koretz, RL | 1 |
Fricke, R | 1 |
Kuzela, L | 1 |
Du Vivier, A | 1 |
Munro, DD | 1 |
Verbov, J | 1 |
Iarmolinskiĭ, IS | 1 |
Goriaĭnov, VA | 1 |
Mikheeva, EV | 1 |
Aksel'rod, II | 1 |
Eales, L | 1 |
Grosser, Y | 1 |
Levey, M | 1 |
Rogers, AI | 1 |
Caravati, CM | 1 |
Hooker, TH | 1 |
Reuber, MD | 1 |
Mazor, Y | 1 |
Koifman, E | 1 |
Elkin, H | 1 |
Chowers, Y | 1 |
Krivoy, N | 1 |
Karban, A | 1 |
Efrati, E | 1 |
Reinshagen, M | 1 |
Schütz, E | 1 |
Armstrong, VW | 1 |
Behrens, C | 1 |
von Tirpitz, C | 1 |
Stallmach, A | 1 |
Herfarth, H | 1 |
Stein, J | 1 |
Bias, P | 1 |
Adler, G | 1 |
Shipkova, M | 1 |
Kruis, W | 1 |
Oellerich, M | 1 |
von Ahsen, N | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pharmacogenetic Testing in the Clinical Setting: is Screening for TPMT Genotype a Cost-effective Treatment Strategy? - The First Prospective Randomized Controlled Trial Within the Dutch Health Care System.[NCT00521950] | 853 participants (Actual) | Interventional | 2007-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
23 reviews available for azathioprine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver In | 2014 |
Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.
Topics: Administration, Oral; Azathioprine; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Cholesta | 2014 |
Ipilimumab-induced toxicities and the gastroenterologist.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury | 2015 |
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Humans; Im | 2015 |
Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
Topics: Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; | 2008 |
Azathioprine-induced liver injury in a patient with multiple autoimmune syndrome.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerativ | 2010 |
Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Azathioprine; Chemical and Dru | 2010 |
Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Chemical and Drug Induced Liver Injury; Global Health | 2007 |
Cyclosporine: a new immunosuppressive agent for organ transplantation.
Topics: Animals; Azathioprine; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Cyclospo | 1984 |
[Diagnosis and treatment of chronic active hepatitis].
Topics: Adrenal Cortex Hormones; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Hepa | 1984 |
Drug-induced hepatic injury.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Aza | 1997 |
[Severe acute hepatitis caused by azathioprine].
Topics: Acute Disease; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Immunosuppressiv | 2001 |
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Topics: Alkylating Agents; Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carcinogens; Chemical a | 1975 |
Liver disease in renal transplant recipients.
Topics: Animals; Azathioprine; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Cholestasis; Ch | 1978 |
[Drug induced liver disease (author's transl)].
Topics: Azathioprine; Bile Acids and Salts; Bilirubin; Biotransformation; Chemical and Drug Induced Liver In | 1978 |
The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.
Topics: Antimalarials; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Humans; | 1990 |
Cytotoxic drugs: their clinical application to the rheumatic diseases.
Topics: Arthritis; Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Cell Division; Chemica | 1986 |
[Liver disease caused by azathioprine: clinical case and review of the literature].
Topics: Aged; Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Leukopenia; Liver Diseases; Male | 1988 |
Advances in medicine.
Topics: Anemia, Macrocytic; Anti-Arrhythmia Agents; Anticoagulants; Azathioprine; Chemical and Drug Induced | 1972 |
Treatment of liver disease with corticosteroids.
Topics: Adrenal Cortex Hormones; Alcoholism; Azathioprine; Chemical and Drug Induced Liver Injury; Glucocort | 1973 |
Chronic hepatitis.
Topics: Adult; Animals; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Ch | 1974 |
Therapeutic considerations in selected forms of acute and chronic liver disease.
Topics: Acute Disease; Age Factors; Alcoholism; Azathioprine; Chemical and Drug Induced Liver Injury; Chroni | 1971 |
7 trials available for azathioprine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans; Inflammatory Bowel Dise | 2017 |
Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies | 2017 |
6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug | 2003 |
Experience with cyclosporine and steroids in clinical renal transplantation.
Topics: Actuarial Analysis; Adult; Azathioprine; Cadaver; Chemical and Drug Induced Liver Injury; Clinical T | 1984 |
Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Follo | 1994 |
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Resistance; Fema | 2002 |
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Crohn Disease; Dose-Response Relati | 2007 |
141 other studies available for azathioprine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Effect of gervital in attenuating hepatotoxicity caused by methotrexate or azathioprine in adult albino rats.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Azathioprine; Chemical and Drug Induced Liver In | 2022 |
Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs.
Topics: Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Dog Diseases; Dogs; Glucocorticoids; | 2022 |
Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients.
Topics: Algorithms; Azathioprine; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adve | 2022 |
Severe azathioprine-induced liver injury 22 months after initiation of treatment.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chroni | 2022 |
Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Fatty Liver; Humans; Inflammatory Bowel Diseas | 2020 |
Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Azathioprine; Carcinoma, Non-Sma | 2020 |
Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Azathioprine; Bilirubin; Chemical and Drug Induce | 2017 |
Azathioprine combination therapy for steroid-refractory hepatic immune system-related adverse events.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Azathioprine; Chemical and Drug Induced Liver I | 2017 |
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Chemical and Drug Induced Liver Injury; Chi-Square Di | 2017 |
Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Allopurinol; Australia; Azathioprine; Chemical and Drug Induced Liver Injur | 2018 |
NUDT15 polymorphism identified in a patient with azathioprine hypersensitivity syndrome presenting as erythema nodosum and hepatotoxicity.
Topics: Adult; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Urticaria; Erythema Nod | 2019 |
Severe cholestasis due to azathioprine in Behcet's disease.
Topics: Adult; Azathioprine; Behcet Syndrome; Chemical and Drug Induced Liver Injury; Cholestasis; Humans; I | 2019 |
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
Topics: Adolescent; Antiviral Agents; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Guanidin | 2019 |
[Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Crohn Disease; Humans; Immunosuppressiv | 2013 |
Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury.
Topics: Animals; Azathioprine; Carrier Proteins; Chemical and Drug Induced Liver Injury; Female; Glutathione | 2014 |
Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
Topics: Adult; Alleles; Alopecia; Asian People; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort | 2014 |
Royal jelly attenuates azathioprine induced toxicity in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Anemia; Animals; Antimetabolites, Antineoplastic; Aspart | 2014 |
Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease.
Topics: Adolescent; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Crohn Disease; Female; Guan | 2014 |
Suspected azathioprine induced liver cirrhosis: an unusual side effect.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans; Immunosuppressive Agents; Live | 2014 |
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprin | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumato | 2015 |
Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.
Topics: Adult; Amyotrophic Lateral Sclerosis; Azathioprine; Benzamides; Biopsy; Chemical and Drug Induced Li | 2015 |
Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.
Topics: Adult; Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Overdose; Drug-Related Si | 2017 |
Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antimetabolites; Azathioprine; Blood Sedime | 2016 |
A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans | 2016 |
Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Azathioprine; Bilirubin; Chemic | 2017 |
Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Moni | 2008 |
6-mercaptopurine as an alternative to azathioprine in azathioprine-induced hepatoxicity.
Topics: Adolescent; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Crohn Disease; Humans; Immu | 2009 |
Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
Topics: Adult; Aged; Asian People; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relat | 2009 |
Meloxicam as a cause of drug-induced autoimmune hepatitis.
Topics: Actin Cytoskeleton; Alanine Transaminase; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-St | 2010 |
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents; Asian People; Azathioprine; Chemica | 2009 |
Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn | 2010 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents | 2010 |
Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
Topics: Acute Disease; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Drug Hyper | 2010 |
Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
Topics: Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Crohn Disease; Diagnosis, Differential | 2010 |
Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Crohn Disease; Female; Humans; Hyperpla | 2011 |
Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?
Topics: Allopurinol; Azathioprine; Biotransformation; Chemical and Drug Induced Liver Injury; Drug Therapy, | 2010 |
[Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Crohn Disease; Humans; Hyperplasia; Hypertensi | 2011 |
Azathioprine induced hepatitis in patients with inflammatory bowel disease.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Immunosuppressive Agents; Inflammatory | 2011 |
British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011.
Topics: Abnormalities, Drug-Induced; Adult; Aged; Azathioprine; Bone Marrow Diseases; Chemical and Drug Indu | 2011 |
Ornidazole-induced autoimmune hepatitis.
Topics: Adult; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Fema | 2011 |
Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Human | 2012 |
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; C | 2012 |
Azathioprine induced liver injury: a case report.
Topics: Azathioprine; Biopsy, Needle; Body Mass Index; Chemical and Drug Induced Liver Injury; Dermatitis; F | 2012 |
A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol.
Topics: Adult; Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relationship | 2013 |
A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine.
Topics: Acetylcysteine; Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Therapy, Combina | 2003 |
Side effects of azathioprine in patients with Crohn's disease.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents; Azathioprine; Chemical and Drug Induced Liver In | 2004 |
Severe cholestatic hepatitis caused by azathioprine.
Topics: Aged; Azathioprine; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Humans; Liver | 2005 |
Hepatoprotective effects of Hibiscus, Rosmarinus and Salvia on azathioprine-induced toxicity in rats.
Topics: Animals; Antimetabolites; Antioxidants; Azathioprine; Chemical and Drug Induced Liver Injury; Hibisc | 2005 |
TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child | 2005 |
Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Biomarkers; Chemical and Drug Induced Liver Injury; Female; H | 2005 |
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Chemical and Drug Induced Liver Injury; Cr | 2006 |
6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?
Topics: Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug | 2006 |
Azathioprine hepatotoxicity and the protective effect of liquorice and glycyrrhizic acid.
Topics: Acetylcysteine; Animals; Azathioprine; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liv | 2006 |
[Infliximab-induced hepatitis in a patient with Crohn's disease].
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; | 2006 |
Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
Topics: Adolescent; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Hype | 2007 |
Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.
Topics: Adult; Algorithms; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Female | 2007 |
Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Azathioprine; Chemical and Drug Induced Liver Injur | 2007 |
[Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].
Topics: Adalimumab; Adolescent; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Humani | 2008 |
[Hepatopathy in kidney transplant patients: incidence, etiology and clinical forms of presentation].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cytomegalovirus Inf | 1984 |
Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Constriction, Pathologic; Hepatic Veins; Human | 1984 |
Serum IgA concentration and hepatotoxicity in rheumatoid arthritis treated with azathioprine.
Topics: Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans; Immunog | 1983 |
[Liver injury in kidney transplant patients receiving azathioprine (author's transl)].
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Azathioprine; Chemical and Drug Induced Liver Inj | 1980 |
Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Graft Rejection; Hu | 1981 |
Cyclosporin A hepatotoxicity in 66 renal allograft recipients.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporins; Dose-Response Relationship, Drug | 1981 |
Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities.
Topics: Adult; Aged; Anorexia; Arthritis, Rheumatoid; Azathioprine; Bacterial Infections; Chemical and Drug | 1982 |
Hepatotoxicity of 6-mercaptopurine and azathioprine.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Liver; Mercaptopurine | 1994 |
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Enzyme-Linked Immunoso | 1996 |
[Mixed hepatitis induced by azathioprine].
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans; Immunosuppressive Agent | 1996 |
[Acute cytolytic hepatitis in azathioprine hypersensitivity].
Topics: Acute Disease; Adult; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Chemical and Drug Induced | 1996 |
Azathioprine-induced lymphoma manifesting as fulminant hepatic failure.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; F | 1997 |
[Post-infantile giant cell hepatitis. Clinical and histological response to immunosuppressive therapy].
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Fibrinolytic Agents; Glucocorticoids; H | 1998 |
[Protective effects of radix Salviae miltiorrhizae on azathioprine hepatotoxicity in rats].
Topics: Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Female; Free R | 1996 |
[Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
Topics: Adult; Ascites; Azathioprine; Chemical and Drug Induced Liver Injury; Cholestasis; Diagnosis, Differ | 1998 |
Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fatal Outcome; Hear | 1999 |
Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Crohn Disease; Cytomegalovirus Infectio | 2000 |
Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Topics: Adolescent; Adult; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Autoantibodies; Autoantigens | 2002 |
[Isoenzyme differentiation of gamma-glutamyltransferase by concanavalin A and Con- A-Sepharose (author's transl)].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Chemical Precipitation; Chromatography, Affini | 1976 |
[Biochemical and morphological study on hepato-toxicity of azathioprine in rat (author's transl)].
Topics: Alkaline Phosphatase; Animals; Azathioprine; Chemical and Drug Induced Liver Injury; gamma-Glutamylt | 1979 |
[Practical aspects of the cytostatic therapy of psoriasis].
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Chemical and Drug Induced Liver Injury; Hu | 1976 |
Spectrum of liver disease in renal transplant recipients.
Topics: Acute Disease; Azathioprine; Bilirubin; Chemical and Drug Induced Liver Injury; Cytomegalovirus; Hep | 1975 |
Hepatic dysfunction in recipients of renal allografts.
Topics: Alanine Transaminase; Alkaline Phosphatase; Antigens, Viral; Aspartate Aminotransferases; Azathiopri | 1975 |
Jaundice after renal allotransplantation.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Transfusion | 1978 |
Biochemical and morphological study on hepatotoxicity of azathioprine in rat.
Topics: Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum; Glucose-6-Phos | 1979 |
Cyclophosphamide (CP) substituting azathioprine after renal transplantation.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Graft Rejection; Humans; Imm | 1976 |
Azathioprine hepatotoxicity, direct complication or secondary effect in rat liver transplantation.
Topics: Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Hepatectomy; Hepatic Artery; Liver; L | 1976 |
[Long-term use of immunosuppressants in patients with kidney transplants].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Gastro | 1975 |
Diagnosis and treatment of chronic active hepatitis.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; He | 1977 |
Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
Topics: Azathioprine; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Humans; Kidney Transplan | 1975 |
[Drug-induced liver diseases].
Topics: Acetaminophen; Adult; Alcoholism; Azathioprine; Bilirubin; Chemical and Drug Induced Liver Injury; C | 1975 |
Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azathioprine; Chemical and Drug Induced | 1975 |
Fever, hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity.
Topics: Acute Disease; Arthritis, Rheumatoid; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; | 1992 |
[Usefulness of ketoconazole combined with cyclosporin in renal transplantation].
Topics: Adolescent; Adult; Azathioprine; Biotransformation; Chemical and Drug Induced Liver Injury; Cyclospo | 1991 |
Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Eruptions; D | 1990 |
Probable azathioprine hepatotoxicity: a case report.
Topics: Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Liver; Male; Mi | 1989 |
Liver disease in renal transplant patients treated with azathioprine or ciclosporin.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporins; Cytomegalovirus Infections; Fema | 1986 |
Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
Topics: Adult; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Hepatic Veins; Hepatic Veno-Occ | 1987 |
Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Endothelium; Female; Hepatomegaly; Huma | 1988 |
Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Humans; Hypert | 1987 |
Bile ductal and ductular changes of the livers in the renal allografted patients.
Topics: Adult; Azathioprine; Bile Ducts, Intrahepatic; Biopsy, Needle; Chemical and Drug Induced Liver Injur | 1987 |
Azathioprine and hepatic venocclusive disease in renal transplant patients.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Hepatic Veins; Humans; Immunosuppressio | 1986 |
Azathioprine hypersensitivity manifesting as acute focal hepatocellular necrosis.
Topics: Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; | 1986 |
Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Chemical and Drug Induced Liver Inju | 1985 |
Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Esophagus; Female; Humans; Hypertension | 1985 |
[Life-threatening interaction between azathioprine and allopurinol].
Topics: Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Synergism; Drug Therapy, Com | 1985 |
Sclerosing hepatitis and azathioprine.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Demyelinating Diseases; Humans; Male | 1986 |
Management of chronic hepatitis.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Hepatitis; Hepatitis | 1971 |
Enzyme histochemical studies of the liver during immunosuppressive treatment in dogs.
Topics: Acid Phosphatase; Adenosine Triphosphatases; Alkaline Phosphatase; Animals; Antilymphocyte Serum; Az | 1970 |
[Diagnosis, therapy and clinical course in chronic active hepatitis in childhood with special reference to immunological findings (author's transl)].
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Azathioprine; Chemical and Drug Induced Liver Inju | 1974 |
[Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; | 1973 |
The treatment of severe myasthenia gravis with immunosuppressive agents.
Topics: Adolescent; Adult; Age Factors; Agranulocytosis; Aminopterin; Azathioprine; Chemical and Drug Induce | 1969 |
Hepatic dysfunction after renal transplantation in children.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Azathiop | 1972 |
Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biliary Tract Diseases; Chemical and D | 1974 |
Irreversible liver damage after azathioprine.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Autopsy; Azathioprine; Chemical and Drug I | 1972 |
Mitochondrial antibody in primary biliary cirrhosis and other diseases.
Topics: Antibodies; Azathioprine; Biliary Tract Diseases; Biopsy; Chemical and Drug Induced Liver Injury; Ch | 1972 |
Chronic immunosuppression, Australia antigenemia, and hepatitis.
Topics: Animals; Azathioprine; Carrier State; Chemical and Drug Induced Liver Injury; Complement Fixation Te | 1972 |
Ultrastructure of peliosis hepatis in a percutaneous biopsy.
Topics: Azathioprine; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum; Heart T | 1972 |
Liver disease in kidney transplant patients receiving azathioprine.
Topics: Adolescent; Adult; Alkaline Phosphatase; Amylases; Aspartate Aminotransferases; Azathioprine; Biliru | 1973 |
Letter: Isoniazid hepatotoxicity.
Topics: Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Glomerulonephritis; Humans; Isoniazid; | 1973 |
[Cyclophosphamide therapy in kidney transplants].
Topics: Adult; Antilymphocyte Serum; Azathioprine; Chemical and Drug Induced Liver Injury; Cyclophosphamide; | 1973 |
[Proceedings: Immunosuppression and treatment of psoriasis using cytostatic agents].
Topics: Aged; Antineoplastic Agents; Azathioprine; Bibliographies as Topic; Chemical and Drug Induced Liver | 1973 |
Letter: Azathioprine and liver disease.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Hepatitis A; Liver; Liver Transplantation | 1974 |
[Cytostatic long-term therapy of rheumatoid arthritis].
Topics: Administration, Oral; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; C | 1972 |
[Toxic lesions of the liver due to immunosuppressive agents].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Humans | 1973 |
Treatment of psoriasis with azathioprine.
Topics: Alcohol Drinking; Anemia; Azathioprine; Biopsy; Blood Cell Count; Chemical and Drug Induced Liver In | 1974 |
[Liver lesions in patients following kidney transplantation].
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans; Kidney Tran | 1969 |
Coproporphyrinuria and heart transplantation: its significance.
Topics: Age Factors; Anemia, Hemolytic; Azathioprine; Chemical and Drug Induced Liver Injury; Electrocardiog | 1970 |
Acute massive hepatic necrosis with fatal liver failure.
Topics: Acute Disease; Adolescent; Adult; Aged; Anticonvulsants; Antitubercular Agents; Azathioprine; Blood | 1971 |
Immunosuppressive treatment in non-transplanted dogs. Azathioprine versus azathioprine-antilymphocyteimmuno-globulin-G.
Topics: Anemia; Animals; Antibodies; Antilymphocyte Serum; Azathioprine; Chemical and Drug Induced Liver Inj | 1969 |
Accentuation of carbon tetrachloride-induced cirrhosis by azathioprine in the rat.
Topics: Animals; Azathioprine; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chola | 1970 |
Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease.
Topics: Adolescent; Adult; Age Factors; Chemical and Drug Induced Liver Injury; Cohort Studies; Crohn Diseas | 2013 |